Oncolys BioPharma (TSE:4588) Accounts Payable & Accrued Expense : 円68.57 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Oncolys BioPharma Accounts Payable & Accrued Expense?

Oncolys BioPharma's quarterly accounts payable & accrued expense increased from Sep. 2023 (円93.10 Mil) to Dec. 2023 (円212.20 Mil) but then declined from Dec. 2023 (円212.20 Mil) to Mar. 2024 (円68.57 Mil).

Oncolys BioPharma's annual accounts payable & accrued expense declined from Dec. 2021 (円165.49 Mil) to Dec. 2022 (円63.79 Mil) but then increased from Dec. 2022 (円63.79 Mil) to Dec. 2023 (円212.20 Mil).

Oncolys BioPharma Accounts Payable & Accrued Expense Historical Data

The historical data trend for Oncolys BioPharma's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncolys BioPharma Accounts Payable & Accrued Expense Chart

Oncolys BioPharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

372.96

240.10

165.49

63.79

212.20

Oncolys BioPharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															57.06	106.99	93.10	212.20	68.57

Oncolys BioPharma Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Oncolys BioPharma (TSE:4588) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncolys BioPharma Inc (TSE:4588) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

4-1-28 Toranomon, Toranomon Towers Office, Minato-ku, Tokyo, JPN, 105-0001

Website

http://www.oncolys.com

Oncolys BioPharma Inc develops pharmaceutical products. The company is engaged in research and development of oncolytic viruses, drugs for serious infectious diseases, molecular targeted anti-cancer drugs, and tumor diagnostic agents.

Oncolys BioPharma (TSE:4588) Headlines

No Headlines